Joshi, A. et al. 2022. Bioequivalence study of a fixed-dose combination of Dapagliflozin/ Vildagliptin Sustained Release tablets in healthy adult male subjects: A Randomized, Open-Label, Crossover Study. Journal of Drug Delivery and Therapeutics. 12, 6 (Nov. 2022), 105–109. DOI:https://doi.org/10.22270/jddt.v12i6.5798.